EAS Newsletter September 3, 2024

Society:

There’s less and less time left! Apply for the EAS Competitive grant now!

One of our Society’s key goals is to ensure that research in atherosclerosis continues to advance for years to come. To achieve this, we strive to support and nurture talented young scientists in the field. For many years, EAS has fostered their careers through travel grants, fellowships, and specialized scientific programs.

This year, a call for applications for the EAS Competitive grant is open until September 13. Apply now to be considered!

Please share this opportunity with your colleagues and encourage those who might benefit from it to apply.

Read more about the criteria and submit your application here:

Society:

Nominate those who deserve recognition. The call for Anitschkow Prize 2025 nominations is now open!

The nomination period for the prestigious Anitschkow Prize 2025 is now open and will run through October 14, 2024. This esteemed prize, presented annually by the EAS, honors outstanding researchers who have made significant contributions to the field of atherosclerosis and related metabolic disturbances.

Nomination criteria
Eligible nominees should:

• be recognized for their groundbreaking research in atherosclerosis and related metabolic disturbances.
• have made outstanding novel contributions that have significantly impacted the discipline.
• maintain an excellent publication record in the field.
• be actively engaged in research.

How to nominate
Nominations can be submitted by any full individual EAS member and must be supported by a peer. Each submission will be carefully evaluated by an independent review panel based on the criteria mentioned above.

Submit your nomination for the Anitschkow Prize 2025 today and seize this opportunity to honor a researcher whose work is advancing the field of atherosclerosis!

Education:

New insights in the genetics of FH by Prof Mafalda Bourbon

MMafalda Bourbon is a senior researcher at the National Institute of Health in Portugal (INSA), where she serves as the coordinator of the R&D Unit and Head of the Cardiovascular Research Group within the Department of Health Promotion and Prevention of Non-Communicable Diseases.

As a leading researcher in the field of genetics of familial hypercholesterolemia (FH), her work has significantly enhanced the identification, functional characterization, and interpretation of variants found in patients with a clinical diagnosis of FH and other dyslipidemias.

In this lecture, she will explore the most recent advances in the genetic diagnosis of FH.

Education:

Our third EAS-LatAm webinar is in high demand! Join the record number of registrants this Thursday

We’ve set a new record for EAS webinar attendance! Our third EAS-LatAm webinar is in high demand, and we invite you to join us for an in-depth discussion on the atherogenic role of triglyceride-rich lipoproteins (TRLs). We’ll also explore the ongoing debate about whether mild or moderate increases in TRLs should be managed pharmacologically.

Thank you for your continued interest, and we look forward to your participation in this exciting webinar. We’ll begin on Thursday at 18:00 CET. Whether you speak English or Spanish, this event will be tailored to suit you.

Education:

Thank you for connecting at ESC Congress 2024!

We’re grateful to everyone who visited our booth and joined our official joint session at ESC Congress 2024. We hope you found the knowledge shared valuable and gained insights into our activities.

Remember, we’re here to continue the conversation and support your needs. Please feel free to reach out to us anytime.

Outreach:

Help us collect 1 million+ signatures for cardiovascular health and save lives

We call on all governments and decision-makers to put an action plan in place to defeat the world’s biggest killer. This petition is for everyone who cares about better health and access to diagnosis, care, and disease prevention.

Cardiovascular disease (CVD) is the leading cause of death, claiming more than 20 million lives every year.

Act now and urge leaders to address CVD with a bold national action plan. Let’s create a productive global community of healthier hearts, supported by smart investments and responsible policies.

To sign the petition, visit the main page of our website and scroll down to find the special widget. Share this initiative with your colleagues.

Collaborations:

17^th Dyslipidemia & Atherosclerosis Webinar Series (DAWAS): To apoB or not to apoB

We are excited to share the invitation to join the upcoming webinar, “To apoB or not to apoB”, organized by our partner, the Korean Society of Lipid and Atherosclerosis (KSoLA), as part of the 2024 17th Dyslipidemia & Atherosclerosis Webinar Series (DAWAS). This informative session will take place on September 5, 2024, from 11:00 to 12:00 (CET).

Registration is not required. To join the webinar, please click the link below:

Society:

EAS Calendar – September 2024

From insightful webinars to groundbreaking announcements, this section is your gateway to staying connected and up-to-date with the latest developments within the EAS Society.

September 2 – October 14, Call for Anitschkow Prize 2025 nominations

September 5, LatAm-EAS: Triglyceride-rich lipoproteins as contributors to residual risk

September 13, EAS Competitive Grant: deadline for the applications

September 20, EAS Advanced Course in Rare Lipid Disorders, Slovenia

September 27, EAS Advanced Course in Rare Lipid Disorders, Greece